Cite
HARVARD Citation
McWilliams, R. et al. (n.d.). 3324 NCCTG N0879 (Alliance): A randomized phase II cooperative group trial of carboplatin, paclitaxel, bevacizumab, =/- everolimus (CPB+/-E) for metastatic melanoma. European journal of cancer. pp. S672-. [Online].